
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
ASC-1 CRISPR/Cas9 KO Plasmid (m) | sc-425141 | 20 µg | $397.00 |
Trip4 encodes ASC-1, a transcriptional coactivator that functions within the Activating Signal Cointegrator-1 (ASC-1) complex to couple sequence-specific transcription factors with RNA polymerase II machinery. ASC-1 contributes to regulation of gene expression programs linked to nuclear receptor signaling and broader transcriptional control, including processes that influence differentiation, metabolism, and cellular stress responses. In mouse systems, Trip4-dependent transcriptional modulation is used to dissect how coactivators integrate signaling inputs to shape chromatin-associated transcriptional outputs. Altered ASC-1 complex function has been associated with dysregulated developmental and neuromuscular gene programs, supporting its relevance for studying disease-associated transcriptional networks without implying clinical outcomes.
Asc-1 CRISPR/Cas9 KO Plasmid (m) is a pool of plasmids designed for targeted disruption of the Trip4 gene in mouse cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the Trip4 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the Trip4 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish Asc-1 protein expression.
This CRISPR knockout system enables efficient generation of Trip4-deficient cell models for investigation of Asc-1 signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.